Bacteriophages articles from across Nature Portfolio

In this study, Gencay et al. develop a cocktail of engineered phages to target clinically relevant Escherichia coli strains.

Phage-encoded endolysins released from neighbouring infected bacterial cells can confer a temporary resistance to phage infection by mediating the reversible loss of the cell wall.

This study shows that Listeria monocytogenes and Enterococcus faecalis can evade phage predation by transient conversion to a cell wall-deficient L-form state.

Phage–antibiotic combination therapy was successful in treating extensively-resistant Pseudomonas aeruginosa infection following liver transplantation in a toddler.

A recent study reports the targeted suppression of an inflammatory bowel disease-associated pathobiont by phage therapy for treatment of intestinal inflammation.